Last reviewed · How we verify

NCT06331507

Refinement and Assessment of New MRI Technologies for Cardiovascular Exams Using the Phillips CMR Patch

Terminated NA Results posted Last updated 17 July 2024
What this trial tests

NA trial testing CMR patch in Cardiomyopathies in 292 participants. Terminated before completion.

Timeline
2 September 2021
Primary endpoint
29 June 2023
29 June 2023

Quick facts

Lead sponsorUniversity of Michigan
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment292
Start date2 September 2021
Primary completion29 June 2023
Estimated completion29 June 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Michigan

Who can join

18 and older, any sex, with Cardiomyopathies. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is being done to improve image quality and provide the collaborator with feedback on wide band imaging in patients with cardiac implantable electronic devices (CIED).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cardiomyopathies

Currently open trials in the same condition.

Other University of Michigan trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06331507.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing